Search

Solution NMR Structure of the Neh1 Domain of Human Nuclear factor erythroid 2-related factor 2 (NRF2)
Authors
Brueschweiler, S.
Assembly
Isoform 3 of Nuclear factor erythroid 2-related factor 2
Entity
1. Isoform 3 of Nuclear factor erythroid 2-related factor 2 (polymer), 81 monomers, 9401.863 Da Detail

GAKHSSRLEA HLTRDELRAK ALHIPFPVEK IINLPVVDFN EMMSKEQFNE AQLALIRDIR RRGKNKVAAQ NCRKRKLENI V


Formula weight
9401.863 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 82.7 %, Completeness: 50.4 %, Completeness (bb): 72.3 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All50.4 % (505 of 1001)41.5 % (219 of 528)59.4 % (224 of 377)64.6 % (62 of 96)
Backbone72.3 % (347 of 480)65.8 % (106 of 161)74.7 % (180 of 241)78.2 % (61 of 78)
Sidechain36.5 % (219 of 600)30.8 % (113 of 367)48.8 % (105 of 215) 5.6 % (1 of 18)
Aromatic 9.5 % (4 of 42)19.0 % (4 of 21) 0.0 % (0 of 21)
Methyl66.0 % (62 of 94)63.8 % (30 of 47)68.1 % (32 of 47)

1. entity 1

GAKHSSRLEA HLTRDELRAK ALHIPFPVEK IINLPVVDFN EMMSKEQFNE AQLALIRDIR RRGKNKVAAQ NCRKRKLENI V

Sample

Solvent system 95% H2O/5% D2O, Pressure 1 atm, Temperature 298 K, pH 6.5, Details 0.5 mM [U-100% 13C; U-100% 15N] neh1, 95% H2O/5% D2O


#NameIsotope labelingTypeConcentration
1neh1[U-100% 13C; U-100% 15N]0.5 mM

Release date
2021-05-05
Citation
A Step Towards NRF2-DNA Interaction Inhibitors by Fragment-Based NMR Methods
Bruschweiler, S., Fuchs, J.E., Bader, G., McConnell, D.B., Konrat, R., Mayer, M.
ChemMedChem (2021), 16, 3576-3587, PubMed 34524728 , DOI 10.1002/cmdc.202100458 ,
Related entities 1. Isoform 3 of Nuclear factor erythroid 2-related factor 2, : 1 : 8 : 46 entities Detail
Interaction partners 1. Isoform 3 of Nuclear factor erythroid 2-related factor 2, : 24 interactors Detail
Experiments performed 12 experiments Detail
Chemical shift validation 3 contents Detail
Keywords DNA BINDING PROTEIN, antioxidant response, basic leucine zipper (bZIP) transcription factor, cap n collar (CNC)